Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03089645
Title MEDI5083 Alone and in Combination With Durvalumab in Subjects With Select Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site Hackensack New Jersey 07601-2191 United States Details
Research Site Providence Rhode Island 02903 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Salt Lake City Utah 84112 United States Details
Research Site Clayton 3168 Australia Details
Research Site Melbourne 3000 Australia Details
Research Site Melbourne 3004 Australia Details
Research Site Randwick 2031 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field